Rocuronium and Supramaximal Stimulation - Trial NCT05294523
Access comprehensive clinical trial information for NCT05294523 through Pure Global AI's free database. This phase not specified trial is sponsored by Taipei Medical University Hospital and is currently Recruiting. The study focuses on Neuromuscular Blockade. Target enrollment is 300 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Taipei Medical University Hospital
Timeline & Enrollment
N/A
Dec 20, 2021
Dec 31, 2024
Primary Outcome
Supramaximal stimulation value
Summary
To shorten induction time, some anesthesiologist gives a priming dose of muscle relaxant
 before starting Neuromuscular Transmission monitor (NMT). To properly evaluate neuromuscular
 function during the surgury, baseline supramaximal stimulation of the monitored nerve is
 mandatory. Not knowing if the priming dose of muscle relaxant affects the supramaximal
 stimulation current setting, The investigators designed this study to find out.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05294523
Non-Device Trial